Get the Stockscreener App
22.37
1.76%
-0.40
Lifemd Inc stock is traded at $22.37, with a volume of 1,958.
It is down -1.76% in the last 24 hours and down -2.36% over the past month.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
See More
Previous Close:
$22.77
Open:
$22.09
24h Volume:
1,958
Relative Volume:
0.78
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.33%
1M Performance:
-2.36%
6M Performance:
-6.99%
1Y Performance:
-0.27%
1-Day Range:
$22.09
$22.43
1-Week Range:
$21.50
$23.28
52-Week Range:
$18.50
$27.44
Lifemd Inc Stock (LFMDP) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
866 351 5907
Address
236 Fifth Avenue, Suite 400, New York
Compare LFMDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
22.37 | 0 | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.69 | 239.56M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.57 | 70.31M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
2.79 | 51.02M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.42 | 42.46M | 28.99M | -39.20M | -3.34M | 0.00 |
|
POM
Pomdoctor Ltd Adr
|
0.3282 | 38.75M | 0 | 0 | 0 | 0.00 |
Lifemd Inc Stock (LFMDP) Latest News
LifeMD Secures New Revolving Credit Facility for Growth - TipRanks
LifeMD (LFMD) Secures $50 Million Credit Facility with Citizens Bank - GuruFocus
LifeMD stock maintains Buy rating at H.C. Wainwright on Wegovy pill launch - Investing.com Nigeria
LifeMD Signs Multiple Material Agreements - TradingView — Track All Markets
LifeMD announces closing of $50 million revolving credit facility with Citizens Bank, N.A. - marketscreener.com
LifeMD, Inc. Closes $50 Million Revolving Credit Facility with Citizens Bank - Quiver Quantitative
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
Telehealth provider LifeMD gets $50M credit line for future moves - Stock Titan
Slimming Down Debt, Bulking Up Growth: Can LifeMD Sustain Momentum Into 2026? - RTTNews
LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill - markets.businessinsider.com
The $149 Disruptor: GoodRx WeightWatchers, LifeMD Aggressively Scale Access to FDA-Approved Wegovy Pill - HIT Consultant
LifeMD, telehealth stocks surge after adding Novo Nordisk’s Wegovy pill to offerings - Investing.com Canada
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Benzinga
LifeMD (LFMD) and GoodRx (GDRX) Surge on Wegovy Pill Launch - GuruFocus
GoodRx, LifeMD gain on offerings for Novo’s Wegovy pill (LFMD:NASDAQ) - Seeking Alpha
LifeMD now offers Wegovy pill for weight management at $149 monthly - Investing.com Australia
LifeMD, Inc. Expands Telehealth Services to Offer Novo Nordisk’s FDA-Approved Oral Wegovy® for Weight Management - Quiver Quantitative
LifeMD Expands Collaboration with Novo Nordisk as - GlobeNewswire
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On January 5th, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - TradingView — Track All Markets
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD stock price target lowered to $8 at Lake Street on weight management headwinds - Investing.com UK
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - markets.businessinsider.com
LFMD’s Unexpected Rally: Assessing Stock Potential - StocksToTrade
What analysts say about LifeMD Inc stockSector Performance Drivers & Affordable Market Trading - earlytimes.in
Momentum Shift: What is the fair value of LifeMD Inc. stock nowTrade Risk Summary & Accurate Buy Signal Alerts - ulpravda.ru
Why LifeMD Inc. stock remains on watchlistsJuly 2025 Reactions & Reliable Volume Spike Trade Alerts - ulpravda.ru
What is the fair value of LifeMD Inc. stock nowMarket Volume Report & High Return Trade Opportunity Guides - ulpravda.ru
Why retail investors pile into LifeMD Inc. stock2025 Short Interest & Reliable Volume Spike Alerts - Улправда
Why LifeMD Inc. stock could rally in 2025Portfolio Update Report & Weekly Breakout Watchlists - Улправда
Will LifeMD Inc. stock see PE expansionJuly 2025 Analyst Calls & Weekly High Return Opportunities - Улправда
Is LifeMD Inc. stock a top momentum playProfit Target & Safe Capital Allocation Plans - DonanımHaber
LifeMD Earnings Notes - Trefis
Can LifeMD Inc. stock beat market expectations this quarterJuly 2025 Momentum & Low Risk Growth Stock Ideas - Улправда
Will LifeMD Inc. stock see insider buyingQuarterly Portfolio Review & AI Driven Stock Price Forecasts - Улправда
How the Narrative Surrounding LifeMD Is Shifting After Recent Earnings and Weight Management Headwinds - Yahoo Finance
Insider Selling: LifeMD (NASDAQ:LFMD) CMO Sells 15,000 Shares of Stock - MarketBeat
LifeMD options imply 13.7% move in share price post-earnings - MSN
Insider Sell: Jessica Friedeman Sells 15,000 Shares of LifeMD In - GuruFocus
Jump Financial LLC Purchases 346,171 Shares of LifeMD, Inc. $LFMD - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Why LifeMD Inc. stock could be next big winnerPortfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
Is LifeMD Inc. stock attractive for retirement portfoliosJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
How Recent Shifts Are Rewriting the Story for LifeMD’s Valuation and Growth Outlook - Yahoo Finance
Hims & Hers Expands Care Scope as Prescription Platforms Evolve - TradingView
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates - MSN
Levi & Korsinsky Moves to SueWallSt for LifeMD, Inc. Investors That Lost Money - The National Law Review
LifeMD Deadline: LFMD Investors with Losses in Excess of $50K Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm (PR Newswire) - Aktiellt
EBIT per share of LifeMD, Inc.8.875% Series A Cumulative Perpetual Preferred Stock – NASDAQ:LFMDP - TradingView
LifeMD stock price target lowered to $8 by Freedom Capital Markets By Investing.com - Investing.com Australia
Lifemd Inc Stock (LFMDP) Financials Data
There is no financial data for Lifemd Inc (LFMDP). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
9.51%
Cap:
|
Volume (24h):